Q: Compass Pathways looks to be in an interesting new market for magic mushroom drugs. What do you think of the shares as an investment? Thank you.

A: Compass Pathways plc (ADR), $36.19, symbol CMPS on Nasdaq (Shares outstanding: 36.7 million; Market cap: $1.4 billion; www.compasspathways.com), was founded in 2015. The company is now testing the psychoactive compound psilocybin, sometimes referred to as “magic mushrooms,” as a therapy for treatment-resistant depression, or… Read More

Get a 5% yield from Abbvie Inc.

Get a 5% yield from Abbvie Inc.

We continue to see attractive investment opportunities for our subscribers in top drug stocks, including this one. We also like spinoffs, which are about as close as you can get to a sure thing in investing.

This company combines both themes and we feel further… Read More